April 26, 2019
Ohara Pharmaceutical said on April 25 that it has entered into a license and joint development agreement with drug discovery biotech J-Pharma for its biliary tract cancer treatment JPH203. The agreement gives Ohara exclusive rights to research, develop, market, and...read more